More about

Nasopharyngeal Cancer

News
February 28, 2025
1 min read
Save

Benefit of radiotherapy for nasopharyngeal carcinoma may vary by time of day

Benefit of radiotherapy for nasopharyngeal carcinoma may vary by time of day

Patients with nasopharyngeal carcinoma who received radiotherapy in the morning survived longer than those who underwent radiotherapy later in the day, according to study results.

News
August 08, 2024
4 min read
Save

‘Sobering’ data show excessive cannabis use increases risk for head and neck cancer

‘Sobering’ data show excessive cannabis use increases risk for head and neck cancer

Individuals with cannabis-related disorder exhibited increased risk for head and neck cancer, results of a retrospective cohort study showed.

News
July 12, 2024
3 min read
Save

Waterpipe tobacco smoking associated with higher risk for death from multiple cancers

Waterpipe tobacco smoking associated with higher risk for death from multiple cancers

Individuals who smoke tobacco using a waterpipe had a higher risk for death from multiple cancer types compared with those who never smoked, according to data from an ongoing cohort study published in JAMA Oncology.

News
October 30, 2023
1 min read
Save

FDA approves Loqtorzi for advanced nasopharyngeal cancer

FDA approves Loqtorzi for advanced nasopharyngeal cancer

The FDA approved toripalimab-tpzi for two indications as treatment for nasopharyngeal carcinoma, making it the first approved therapy for this malignancy.

News
July 21, 2023
1 min read
Save

FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies

FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies

The FDA granted fast track designation to two oncology therapies.

News
December 05, 2022
2 min read
Save

COVID-19 vaccination may improve efficacy of treatment for nasopharyngeal cancer

COVID-19 vaccination may improve efficacy of treatment for nasopharyngeal cancer

Patients with nasopharyngeal cancer who underwent COVID-19 vaccination had a better response to a combination of anti-PD-1 therapy and chemotherapy than their unvaccinated counterparts, according to a letter published in Annals of Oncology.

News
April 21, 2022
3 min read
Save

Tislelizumab regimen confers clinically meaningful PFS benefit in nasopharyngeal cancer

Tislelizumab regimen confers clinically meaningful PFS benefit in nasopharyngeal cancer

The addition of tislelizumab to chemotherapy conferred a clinically meaningful PFS benefit among patients with recurrent or metastatic nasopharyngeal cancer, according to updated results of the randomized phase 3 RATIONALE-309 study.

News
October 11, 2021
2 min read
Save

Nasopharyngeal cancer incidence varies among Asian American subgroups

Nasopharyngeal cancer incidence varies among Asian American subgroups

Incidence of nasopharyngeal cancer differed greatly among Asian American ethnic subgroups, with significantly higher risk among Chinese and Laotian individuals compared with white individuals, according to study results.